PP
GWPH

Paloma Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Paloma Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,830
Closed -$770K – 2377
2018
Q1 		$770K Buy
+6,830
New +$859K 0.01% 1124
2014
Q4 		– Sell
-3,480
Closed -$281K – 1446
2014
Q3 		$281K Buy
+3,480
New +$308K 0.01% 738

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Paloma Partners's GWPH Position: Q2 2018 in Review

Paloma Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2018, closing a stake of 6,830 shares — an estimated $770K sold.

Paloma Partners first reported a position in GWPH in Q3 2014 and held it in 2 quarters. The position peaked at $770K in Q1 2018. 254 funds tracked by Wall St. Rank hold GWPH as of Q2 2018.

  • Paloma Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Paloma Partners sold 6,830 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2018, an estimated $770K.
  • Paloma Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2014 and held it in 2 quarters.
  • Paloma Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $770K in Q1 2018.
  • 254 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2018.

Based on Paloma Partners's 13F filing for Q2 2018, filed 14 Aug 2018.